3 results match your criteria: "Institute of Oncology Prof. Dr. I. Chiricuta Cluj-Napoca[Affiliation]"
Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors-Results of Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey.
Cancers (Basel)
November 2023
Department of Gynecology with Center for Oncological Surgery, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Article Synopsis
- The survey aimed to understand the health concerns and characteristics of long-term ovarian cancer survivors (LTS) to improve follow-up care.
- Conducted by NOGGO and shared with ENGOT and GCIG members, the anonymous survey included 68 questions and gathered responses from 1,044 LTS across 14 countries.
- Findings highlighted that LTS who survived 5-10 years reported worse health than those over 10 years, with almost half experiencing persistent symptoms like fatigue and pain, emphasizing the need for specialized long-term care.
Association of Parathyroid and Differentiated Thyroid Carcinomas: A Narrative Up-To-Date Review of the Literature.
Medicina (Kaunas)
August 2022
Institute of Oncology Prof. Dr. I. Chiricuta Cluj-Napoca, 400015 Cluj-Napoca, Romania.
Parathyroid carcinoma (PC) is a rare endocrine malignancy that represents 0.005% of all malignant tumors. Associated PC and differentiated thyroid carcinoma (DTC) is an exceptionally rare condition, and the preoperative diagnostics and proper treatment are challenging.
View Article and Find Full Text PDFComparative in vitro study regarding the biocompatibility of titanium-base composites infiltrated with hydroxyapatite or silicatitanate.
J Biol Eng
July 2014
The Institute of Oncology "Prof. Dr. I. Chiricuta" Cluj-Napoca, Cluj-Napoca, Romania ; University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj-Napoca, Cluj-Napoca, Romania.
Background: The development of novel biomaterials able to control cell activities and direct their fate is warranted for engineering functional bone tissues. Adding bioactive materials can improve new bone formation and better osseointegration. Three types of titanium (Ti) implants were tested for in vitro biocompatibility in this comparative study: Ti6Al7Nb implants with 25% total porosity used as controls, implants infiltrated using a sol-gel method with hydroxyapatite (Ti HA) and silicatitanate (Ti SiO2).
View Article and Find Full Text PDF